Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 8.573\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1c(NC(=O)CCC2CCCCC2)cc(C(=O)N2CCOCC2)cc1[N+](=O)[O-]
b CCCN(CCC)C(=O)Cn1c(=O)c2sccc2n2c(=S)sc(-c3ccccc3)c12
Answer: b. CCCN(CCC)C(=O)Cn1c(=O)c2sccc2n2c(=S)sc(-c3ccccc3)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCN(CCC)C(=O)Cn1c(=O)c2sccc2n2c(=S)sc(-c3ccccc3)c12
CCCN(CCC)C(=O)Cn1c(=O)c2sccc2n2c(=S)sc(-c3ccccc3)c12
2-(7-oxo-10-phenyl-12-sulfanylidene-5,11-dithia-1,8-diazatricyclo[7.3.0.02,6]dodeca-2(6),3,9-trien-8-yl)-N,N-dipropylacetamide